KCSVEN: Your posts are interesting and certainly carry your POV.
I must ask you to share your thinking explaining THE CEO'S selling
into the approval? In 19 years in the business, I can't recall a
successful Mgmt Team being successful following a script that destroyed shareholder value, following pumping the stock with BO
rumors, and then selling. This Board has great resources, and is sharp on the Science. My lament is their forgiving nature toward Mgmt. I agree that execution has not been stellar, but that falls into the lap of Mgmt. What has the Board contributed ? I sit on the Board of 2 publicly traded Biotech Co's and with my fellow directors are proactive in helping the CEO create share holder value. I'm not trying to crucify Mgmt, but rather trying to point out that nothing happens for nothing. Hedge Funds hate uncertainty, and have issues with poor execution and lack of leadership. We can respectfully agree to disagree. The reason I'm still on board is that the fundamentals are quite compelling, and the price dislocation reflects the street's lack of confidence in Mgmt. Vascepa has blockbuster potential, and the PPS has nothing to do
with all the snake oil BS.